• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

What's to Blame for Variable Home BP in Patients With Diabetes?

Article

Here: factors that can affect home BP readings . . .when to start antiretroviral therapy . . . coping strategies for the challenges of aging . . . triggers to avoid in hyperthyroid patients . . . insights into causes of childhood obesity.

 

Question 1:

Certain modifiable risk factors affect variability in home blood pressure in patients with type 2 diabetes mellitus.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 2:

The START trial, which recently completed enrollment, will address one of the key clinical questions in HIV management: when is the optimal time to start antiretroviral therapy.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 3:

At age 65 to 70 years, most men begin to report difficulties in coping with health problems, cognitive decline, and loss of a spouse.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 4:

Thyrotoxic periodic paralysis (TPP) is characterized by episodes of muscle weakness in persons with hyperthyroidism.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 5:

New CDC data show that the prevalence of obesity among 2- to 5-year-old children dropped from nearly 14% in 2003-2004 to slightly more than 8% in 2011-2012, a 43% decline.

ANSWER KEY »


For the discussion, click here.


 

ANSWER KEY:

Question 1. B

Question 2. A

Question 3. E

Question 4. D

Question 5. E

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
Adults with Obesity Who Receive Semaglutide as First Weight Loss Medication Lose More Weight / image credit ©brovarky/stock.adobe.com

Adults with Obesity Who Receive Semaglutide as First Weight Loss Medication Lose More Weight

April 25th 2024
Article

Adults receiving semaglutide for the first time achieved weight loss of 14.3% at 12 months vs 10.6% among those who had previously taken a different antiobesity drug.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

ACP issues guidelines on newer pharmacologic treatment for adults with type 2 diabetes/ image credit: medication pens:©felipecaparros/stock.adobe.com

ACP Recommends SGLT2i, GLP1 RA After Metformin to Manage Cardiorenal Comorbidities in Adults with Type 2 Diabetes

April 22nd 2024
Article

Based on the classes' cardio- and renoprotective benefits, the ACP recommends SGLT2i and GLP1RA as second-line therapy in adults with T2D who are most likely to benefit.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Decrease in BMI Linked to Increased Risk for Severe Exacerbations, All-Cause Mortality in COPD / image credit weight loss/gain: ©missbobbit/stock.adobe.com

Decrease in BMI Linked to Increased Risk for Severe Exacerbations, All-Cause Mortality in COPD

April 19th 2024
Article

Among persons with COPD whose BMI decreased over a 4-year follow-up, mortality risk rose 70% compared with those whose BMI remained the same, researchers reported.

Navigating the New Wave of Antiobesity Medications: What Primary Care Clinicians Should Know / Image credit: ©Antonio Diaz/AdobeStock

Navigating the New Wave of Antiobesity Medications: What Primary Care Clinicians Should Know

April 17th 2024
Article

With the rise in demand for newer antiobesity medications, clinicians may face more questions from patients. Here, a primer on the drawbacks and benefits to keep in mind.

© 2024 MJH Life Sciences

All rights reserved.